Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-11-27

Clinical Trial Update: Dexamethasone for Palliation - Brain Metastases [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating dexamethasone for palliation in brain metastases has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DEXAMETHASONE (Dexamethasone)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Neoplasm Metastasis | Phase 2 | Status: COMPLETED